Characterizing Fatigue Subtypes in Adolescents with Chronic Musculoskeletal Pain and Pain-Free Controls.
disability
fatigue
musculoskeletal pain
pediatric
widespread bodily pain
Journal
Journal of pain research
ISSN: 1178-7090
Titre abrégé: J Pain Res
Pays: New Zealand
ID NLM: 101540514
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
02
2022
accepted:
08
07
2022
entrez:
4
8
2022
pubmed:
5
8
2022
medline:
5
8
2022
Statut:
epublish
Résumé
General fatigue, sleep-related fatigue, and cognitive fatigue are prevalent and disruptive in adults with chronic musculoskeletal (MSK) pain, but little is known about these fatigue subtypes in pediatric musculoskeletal pain. To compare fatigue and its subtypes between adolescents with chronic MSK pain and pain-free controls and to test if fatigue subtypes were associated with concurrent pain and its impact (pain intensity, number of pain sites, pain interference, and functional disability) or experimental pain (intensity and tolerance) in adolescents with chronic MSK pain. Finally, we sought to explore adolescents' qualitative characterizations of their fatigue. Adolescents with chronic MSK pain (12-17 y.o., n = 26) and pain-free controls (n = 26) completed validated self-report measures of fatigue, pain, and functional disability, underwent an experimental pain tolerance task (cold water immersion of the hand), and provided qualitative descriptions of their fatigue (pain group only). Adolescents with chronic MSK pain reported significantly greater general, sleep-related, and cognitive fatigue than pain-free controls (all This preliminary study suggests that fatigue subtypes are prevalent and impactful in pediatric patients with chronic MSK pain. When planning multi-disciplinary treatment for pediatric MSK pain, providers should recognize fatigue as another disabling symptom.
Identifiants
pubmed: 35923839
doi: 10.2147/JPR.S363912
pii: 363912
pmc: PMC9341362
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2041-2049Informations de copyright
© 2022 Boggero et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Pain. 2008 Mar;9(3):226-36
pubmed: 18088558
Clin J Pain. 2017 Mar;33(3):231-237
pubmed: 27258993
Pain. 2010 Jul;150(1):173-182
pubmed: 20554116
Clin Med (Lond). 2021 Jan;21(1):19-27
pubmed: 33479064
Pain Med. 2020 Sep 1;21(9):1961-1970
pubmed: 32337554
Physiother Theory Pract. 2017 Jan;33(1):31-40
pubmed: 27898261
Pediatr Diabetes. 2009 Aug;10(5):321-8
pubmed: 19067887
Cancer. 2002 Apr 1;94(7):2090-106
pubmed: 11932914
Semin Arthritis Rheum. 2016 Apr;45(5):587-95
pubmed: 26656031
Clin J Pain. 2009 Jun;25(5):407-12
pubmed: 19454874
Neuroimmunomodulation. 1997 May-Jun;4(3):134-53
pubmed: 9500148
J Oral Facial Pain Headache. 2016 Spring;30(2):99-106
pubmed: 27128473
J Pediatr Psychol. 1991 Feb;16(1):39-58
pubmed: 1826329
Pediatr Blood Cancer. 2014 Jan;61(1):171-7
pubmed: 24038960
Psychophysiology. 2019 Sep;56(9):e13388
pubmed: 31049991
J Pain. 2012 Sep;13(9):817-26
pubmed: 22846592
Eur J Pain. 2010 Mar;14(3):327-34
pubmed: 19540139
J Oral Facial Pain Headache. 2014 Winter;28(1):38-45
pubmed: 24482786
J Pain Symptom Manage. 2020 Jun;59(6):1320-1343
pubmed: 31866485
Int J Pediatr Obes. 2010;5(1):34-42
pubmed: 19593727
J Pediatr. 2016 Feb;169:181-7.e1
pubmed: 26545727
Eur J Pain. 2019 Sep;23(8):1548-1562
pubmed: 31131940
J Pain. 2015 Mar;16(3):291-8.e1
pubmed: 25536536
Pain Res Treat. 2014;2014:653592
pubmed: 24579046
Int J Environ Res Public Health. 2020 Aug 27;17(17):
pubmed: 32867186
J Rheumatol. 2004 Dec;31(12):2494-500
pubmed: 15570657